Narendra Modi govt’s coronary stents policy is Indira Gandhi-style statist meddling
- Opinion | Singapore-India connect: Who has upper hand in NSE, SGX negotiations
- Opinion | Positives of the UN treaty on biz and human rights
- PE’s affinity to financial services: A short-term or a long-term phenomenon?
- Opinion | Retooling time for Artificial Intelligence
- Opinion | Reimagining fiduciaries in the digital economy
Here is how a handbook of bad policy would read. First impose price controls. Then watch goods disappear from the market. And finally, threaten producers with punishment for the shortages that your price controls have created.
This is exactly what is happening in India right now. The Narendra Modi government first imposed price caps on coronary stents. Shortages began to develop as companies cut supplies since production costs are higher than revenues. The government has now thrown the oversized regulatory book at stent manufacturers. They have been directed to maintain domestic production as well as imports of coronary stents. And— hold your breath—to submit a weekly report on production and distribution of coronary stents, as well as a weekly production plan.
Welcome to India, 2017. Welcome to an India ruled by a regime that promised minimum government. Welcome to an India where officials swear they are working hard to make it easier for companies to do business. If the coronary stents policy is not Indira Gandhi-style statist meddling, what is?
Editor's Picks »
- DGCA advises airlines not to overprice air tickets to Kerala
- Tech, not Turkey, proves catalyst behind global sell-off
- Why Zuckerberg buying Messi’s magic on TV is a perfect game for Facebook
- Tencent stuns with first profit drop in a decade
- Proxy advisory firm seeks change in voting rules for related-party transactions